Renal cell carcinoma (RCC) are characterized by frequent VHL (Von Hippel-Lindau) mutations—which, by activating the pathways related to HIF-1α and further VEGF (Vascular Endothelial Growth Factor) [10], makes them highly angiogenic tumors [11]. The gene discussed is VEGFA; the disease is hereditary clear cell renal cell carcinoma.